This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

5 Biotech Stocks to Trade in February

 DELAFIELD, Wis. (Stockpickr) -- The biotechnology sector is in focus the next two days on Wall Street as the BIO CEO & Investor Conference gets underway. This conference is in its sixteenth year, and it's the largest investor conference focused on established and emerging publicly traded and select private biotech companies. The event gives institutional investors, industry analysts and senior biotechnology executives a chance to openly discuss biotech firms' prospects and the ever-changing world of biotechnology.

>>5 Hated Earnings Stocks You Should Love

Traders, like myself, will be focusing on trading any momentum off the fast-moving small-cap biotechnology stocks that will be in play as the companies present at BIO CEO. I have been scanning the charts of many these names looking for some potential fast trades that could play out nicely over the next two days and potentially the next few months. I have found a number of bullish small-cap biotech stocks that will be presenting at the conference, so all we need now is for these stocks to get some volume and break out and we could easily bank some serious short- and mid-term profits.

The stocks I picked aren't just flagging decent setups into their presentations, but they also have longer-term bullish setups. These are names to keep on your trading radar even if we don't get any momentum into the conference or off their presentations. That being said, if the CEOs of these biotech stock say anything bullish that the market likes, then look out, because these stocks could make explosive moves.

>>5 Biotech Stocks Spiking on Unusual Volume

With that in mind, here's a look at five stocks that are scheduled to present at the conference on Tuesday that could make sharp spikes higher.

1 of 6

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,279.74 +13.75 0.08%
S&P 500 2,010.40 -0.96 -0.05%
NASDAQ 4,579.7890 -13.6380 -0.30%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs